Patient Outcomes

Related by string. Patient Outcome * PATIENTS . PATIENT . Patients : Breast Cancer Patients . terminally ill patients . Patient Safety / OUTCOME . OUTCOMES . outcomes : Improving Patient Outcomes . Predicted Outcome . Main Outcome Measures * inVentiv Patient Outcomes . Improving Patient Outcome . Improve Patient Outcomes . Spine Patient Outcomes . Evaluating Patient Outcomes *

Related by context. All words. (Click for frequent words.) 78 Carotid Stenting 77 Rheumatoid Arthritis Patients 76 Acute Coronary Syndromes 76 Heart Failure Patients 75 Platelet Inhibition 74 Stent Thrombosis 74 Patients Undergoing 74 Patients Receiving 73 Inflammatory Markers 73 Cardiovascular Outcomes 73 Venous Thromboembolism 73 Pooled Analysis 73 Acute Myocardial Infarction 73 Clinical Outcome 73 Statistically Significant 72 Elderly Patients 72 Ischemic Stroke 72 Survival Benefit 72 Statin Therapy 72 Renal Cell Carcinoma 72 Pivotal Trial 72 Improves Outcomes 72 Oral Fingolimod 72 Improve Outcomes 72 Obese Patients 72 Subgroup Analysis 72 Acute Heart Failure 72 Heart Transplant Recipients 72 Renal Function 72 Improve Survival 71 Multiple Myeloma Patients 71 Lung Injury 71 Newly Diagnosed Multiple Myeloma 71 Colorectal Cancer Patients 71 Prospective Randomized 71 Fracture Risk 71 Resistant Hypertension 71 Acute Myocardial 71 ST Segment Elevation 71 Improves Survival 71 Critically Ill Patients 71 Advanced Melanoma 71 Gastric Cancer 71 Investigational Drug 71 Combo Therapy 71 Fungal Infections 71 Lung Cancer Trial 71 Pivotal Phase III 71 Prostate Cancer Patients 71 Dialysis Patients 71 Severe Sepsis 71 Overactive Bladder 71 Combination Treatment 71 Clinical Trial Data 71 Patients Treated 71 Knee Osteoarthritis 71 Diabetic Patients 71 Minimally Invasive Treatment 71 Breast Cancer Recurrence 71 Acute Ischemic Stroke 71 Infarction 71 Long Term Outcomes 71 Survival Rates 71 Kidney Function 71 Renal Cancer 71 Hospitalized Patients 71 ST Elevation Myocardial 71 Pediatric Patients 71 Lung Cancer Survival 71 Patients Treated With 71 Long Term Efficacy 71 Adjuvant Chemotherapy 71 Pulmonary Arterial Hypertension 71 Randomized Study 71 Improved Survival 71 Clinical Trial Results 70 Relapsing Multiple Sclerosis 70 Lung Cancer Patients 70 Clinical Evaluation 70 Guideline Update 70 First Patient Enrolled 70 Pivotal Clinical Trial 70 Urinary Incontinence 70 Bloodstream Infections 70 Percutaneous Coronary Intervention 70 Tumor Response 70 Patient Enrollment 70 Randomized Clinical Trial 70 Left Ventricular 70 Phase III Clinical Trial 70 Invasive Breast Cancer 70 Liver Failure 70 Study Showed 70 Antiplatelet Therapy 70 Hypercholesterolemia 70 Coronary Artery Bypass Graft 70 Randomized Trials 70 Drug Eluting Stents 70 Demonstrates Positive 70 Increased Mortality 70 Cardiovascular Events 70 Unfractionated Heparin 70 Severe Asthma 70 Risk Stratification 70 Stenting 70 Randomized Controlled Trials 70 Inhaled Nitric Oxide 70 Septic Shock 70 Meets Primary Endpoint 70 Cardiotoxicity 70 Acute Decompensated Heart Failure 70 Less Invasive 70 Bare Metal Stents 70 Relapsed Multiple Myeloma 70 Multicenter Trial 70 Shows Efficacy 70 Aortic Stenosis 70 Prostate Cancer Treatment 70 Glycemic Control 70 Dual Antiplatelet Therapy 70 Catheter Ablation 70 Recurrent Breast Cancer 70 Neoadjuvant Chemotherapy 70 Treated Patients 70 Clinical Outcomes 70 Hip Fractures 70 Cognitive Impairment 69 Phase III Trial 69 Patency 69 Metastatic Renal Cell Carcinoma 69 Drug Prevents 69 Outpatient Setting 69 Infarct 69 HCV Protease Inhibitor 69 Phase IIb Clinical Trial 69 Myocardial Ischemia 69 Metabolic Disorder 69 Metastatic Prostate Cancer 69 Phase 2b Study 69 Surgical Procedures 69 NDA Submission 69 Sustained Efficacy 69 Demonstrates Significant 69 Localized Prostate Cancer 69 HER2 Positive Breast Cancer 69 Renal Artery 69 Hormone Receptor Positive 69 JAK Inhibitor 69 Investigational Agent 69 Meta Analysis 69 Schizophrenia Treatment 69 Phase 2b Clinical Trial 69 Skin Lesions 69 Kidney Transplant Patients 69 Beta Blocker 69 Carotid Endarterectomy 69 Unstable Angina 69 Epilepsy Drug 69 Nymox NX 69 Allergic Rhinitis 69 Prolongs Survival 69 Hip Fracture 69 Hypertensive Patients 69 Surgical Treatment 69 Appears Safe 69 Myeloma Patients 69 Breast Cancer Treatment 69 Post Operative 69 Investigational Treatment 69 Blood Cancers 69 Renal Anemia 69 Antitumor Activity 69 Thrombolysis 69 Chronic Heart Failure 69 Metastatic Colorectal Cancer 68 Medication Errors 68 Drug Coated Stents 68 Diabetic Foot Ulcer 68 Phase IIb Trial 68 Gene Variation 68 Randomized Controlled 68 Disease Progression 68 Sustained Reduction 68 Stent Restenosis 68 FDA Approvals 68 Phase III Trials 68 Treatment Outcome 68 Pivotal Study 68 Study Evaluating 68 Adverse Event 68 Controlled Trial 68 Laryngeal Cancer 68 Prophylactic Treatment 68 Carotid Artery Stenting 68 Osteoarthritis Patients 68 Osteoporosis Drugs 68 Thromboembolic 68 Adjuvant Therapy 68 Coronary Revascularization 68 Chemotherapeutic Agents 68 Pneumococcal Vaccine 68 Hemodialysis Patients 68 Left Atrial 68 Randomized Evaluation 68 Thrombotic 68 Breast Density 68 Nesiritide 68 Lupus Drug 68 Patients Enrolled 68 Complication Rates 68 Kidney Transplants 68 First Patient Treated 68 Diabetic Neuropathy 68 Medication Adherence 68 Hepatitis C Treatment 68 Improved Outcomes 68 Mortality Risk 68 Prognostic Factors 68 Valvular Heart Disease 68 Long Term Survival 68 Advanced Pancreatic Cancer 68 Statin Drugs 68 Hepatocellular Carcinoma 68 Phase 2b Trial 68 Chronic Sinusitis 68 Autologous Stem Cell Transplantation 68 Adjuvant Breast Cancer 68 Treating Chronic 68 Fewer Side Effects 68 Carotid 68 Cutaneous T 68 Postmenopausal Women 68 Prognostic Value 68 Juvenile Idiopathic Arthritis 68 Acute Pancreatitis 68 Antiplatelet 68 Aggressive Reduction 68 Cholesterol Lowering Drug 68 Multicenter Randomized 68 Cervical Dysplasia 68 Estrogen Therapy 68 Adjuvant Treatment 68 Bone Metastases 68 Uterine Fibroids 68 Clinical Efficacy 68 Artery Disease 68 Demonstrates Sustained 68 Rotavirus Vaccine 68 Reduces Mortality 68 Slow Progression 68 Predict Risk 67 Patients Suffering 67 Preterm Labor 67 Hernia Repair 67 Novel Antibiotic 67 Myelodysplastic Syndromes 67 Treatment Regimen 67 Cardiometabolic 67 Hematopoietic Stem Cell Transplantation 67 Functional Outcomes 67 Pulmonary Artery 67 Uterine Fibroid Embolization 67 Respiratory Distress 67 Intravenous Formulation 67 Dyslipidemia 67 Complete Remission 67 Genes Predict 67 Atherothrombosis 67 Fondaparinux 67 Clinical Trial Evaluating 67 Minimally Invasive Procedure 67 Fibromyalgia Pain 67 Non Inferiority 67 Showed Significant 67 Emerging Therapies 67 Solid Tumors 67 Asthma Treatment 67 II Clinical Trial 67 Controlled Study 67 Treating Depression 67 Prognostic Significance 67 Radiation Dose 67 Intracerebral Hemorrhage 67 Treatment Naive Patients 67 Lowers Risk 67 Circulating Tumor Cells 67 Placebo Controlled Trial 67 Demonstrates Efficacy 67 Newly Diagnosed Patients 67 Advanced Prostate Cancer 67 Insulin Sensitivity 67 MRSA Infections 67 See CLINICAL PHARMACOLOGY 67 Chronic Bronchitis 67 Sleep Disturbances 67 Demonstrate Significant 67 Refractory Angina 67 Ischemic 67 Dose Escalation 67 Pivotal Phase 67 Endovascular Treatment 67 Androgen Deprivation Therapy 67 Chronic Myeloid Leukemia 67 Clostridium difficile Infection 67 Acne Drug 67 Pivotal Trials 67 Decompensated Heart Failure 67 Insulin Therapy 67 Neoadjuvant 67 Intracranial Aneurysms 67 Aortic Valve Replacement 67 Hormone Refractory Prostate Cancer 67 Prospective Multicenter 67 Randomized Double blind 67 Prostate Cancer Recurrence 67 Premature Infants 67 Vertebral Fracture 67 Significant Reduction 67 Peptic Ulcer 67 Retinal Vein Occlusion 67 Total Knee Arthroplasty 67 Coronary Angiography 67 Viral Suppression 67 Osteoporosis Drug 67 Anti Clotting Drug 67 Organ Rejection 67 Brain Metastases 67 Reduce Mortality 67 Prostate Biopsy 67 Brain Aneurysms 67 Left Ventricular Hypertrophy 67 Gout Drug 67 Kidney Failure 67 EHR Adoption 67 Bivalirudin 67 Relapsing Remitting Multiple Sclerosis 67 Reduced Risk 67 Beta Blockers 67 CT Angiography 67 Preterm Delivery 67 Abciximab 67 Malignant Glioma 67 Treat Heart Failure 67 Coronary Artery Calcium 67 IND Filing 67 Venous Thrombosis 67 Targeted Therapies 67 Diabetic Kidney Disease 67 Lupus Nephritis 67 Cancer Recurrence 67 Proven Effective 67 Transplant Patients 67 Significantly Improved 67 Chronic Renal Failure 67 Bone Fracture 67 Aneurysm Repair 67 Valsartan 67 Obese Teens 67 Cardiac Resynchronization 67 Malignant Melanoma 67 Double Blind Placebo 67 Autoimmune Disease 67 Stent Implantation 67 Thromboembolism 67 Previously Treated 66 MMR Vaccine 66 Treatment Reduces 66 Renal Impairment 66 Orthostatic Hypotension 66 Bone Mineral Density 66 Myocardial Infarction Study 66 Drug Shows Promise 66 Therapy Reduces 66 Phase 2a Clinical Trial 66 Boosts Survival 66 Lung Function 66 Drug Coated Stent 66 Castration Resistant Prostate Cancer 66 Contrast Agent 66 Bipolar Depression 66 Study Demonstrates 66 Phase III Clinical Trials 66 Stem Cell Treatment 66 Investigational Compound 66 Adverse Outcomes 66 Nicotine Vaccine 66 Immunomedics Announces 66 Cardiovascular Disease Risk 66 Interventional Procedures 66 ACE Inhibitors 66 Radiofrequency Ablation 66 Atopic Dermatitis 66 Peripheral Arterial 66 STRIDE PD 66 Autoimmune Diseases 66 Cardiogenic Shock 66 Kidney Transplantation 66 Monotherapy 66 Anemia Drug 66 Cognitive Function 66 Skeletal Muscle 66 Randomized Clinical Trials 66 Inhaled Steroids 66 Bone Marrow Transplants 66 Thrombolytic Therapy 66 Phase 1b Clinical Trial 66 Antipsychotic Medications 66 Diamyd Medical Diamyd 66 Drug Combo 66 Blood Pressure Drug 66 Novel Therapies 66 Vascular Disease 66 Secondary Hyperparathyroidism 66 Bare Metal Stent 66 Tiotropium 66 Depressive Symptoms 66 Transplant Rejection 66 Cholesterol Levels SPARCL 66 Ovarian Cancer Patients 66 Treating Heart Failure 66 Drug Candidate 66 Cancer Treatments 66 Drug Eluting 66 Excessive Sweating 66 Advanced Colorectal Cancer 66 Renal Failure 66 Spectrum Pharmaceuticals Announces 66 Viral Infections 66 Antipsychotic Drug 66 Disease Severity 66 Well Tolerated 66 Symptom Relief 66 Lung Cancer Drug 66 Cholesterol Levels 66 Neuroprotective Effects 66 Gene Linked 66 Premenopausal Women 66 HORIZONS AMI 66 Migraine Headaches 66 Non Invasive Treatment 66 Nonalcoholic Steatohepatitis 66 RENAL 66 Radical Prostatectomy 66 Preclinical Data 66 Chronic Lymphocytic Leukemia 66 Tumor Growth 66 dual endothelin receptor antagonist 66 Endovascular Repair 66 Medtronic CoreValve ® 66 Ischaemic 66 Aggressive Prostate Cancer 66 Reperfusion Injury 66 Cardiac Resynchronization Therapy 66 Plaque Psoriasis 66 Insulin Glargine 66 Drug Eluting Stent 66 Comorbidities 66 Diuretic 66 Gene Variants 66 Cardiovascular Risk 66 Contrast Agents 66 Catheter Associated 66 Percutaneous Tibial Nerve Stimulation 66 Myocardial Infarction 66 Combination Therapy 66 Anticoagulants 66 Blood Pressure Reduction 66 Muscle Wasting 66 Embolic Protection 66 Preclinical Models 66 Inhaled Corticosteroids 66 Cardiac Arrest Patients 66 Osteoarthritis Pain 66 Often Misdiagnosed 66 Systolic Blood Pressure 66 Genes Identified 66 Adverse Effects 66 Significantly Reduced 66 Breast Cancer Patients 66 Immunosuppression 66 Lung Cancers 66 Balloon Angioplasty 66 Aromatase Inhibitors 66 Guidelines Issued 66 Lung Tumors 66 Kidney Transplant Recipients 66 Drug Fails 66 Study Evaluates 66 Hepatotoxicity 66 Improve Patient Outcomes 66 Hospital Acquired Pneumonia 66 Prostate Cancers 66 Inhaled Insulin 66 Proves Effective 65 Coronary Artery 65 Diastolic Heart Failure 65 Spinal Fractures 65 Ranolazine 65 Newly Diagnosed Breast Cancer 65 Implantable Cardioverter Defibrillators 65 Breast Tumors 65 Novel Treatments 65 Shown Effective 65 Novel Oral 65 Deep Venous Thrombosis 65 Genetic Markers 65 Phase III Pivotal Trial 65 Menopausal Women 65 Dialysis Outcomes 65 Topline Results 65 Significantly Improves 65 Trodusquemine MSI 65 Completes Enrollment 65 Blocked Arteries 65 Vulnerable Plaque 65 Arthritis Drug 65 Genetic Tests 65 Physical Function 65 Antihypertensive 65 Guidelines Recommend 65 Diabetic Foot Ulcers 65 Prostatectomy 65 Prostate Surgery 65 Randomized Double Blind 65 Primary Endpoint 65 Shows Promising 65 Hyperkalemia 65 Treatment Outcomes 65 Recurrent Stroke 65 Peripheral Artery Disease 65 Dendritic Cells 65 FDA Okays 65 ADHD Medication 65 Total Knee Replacement 65 Randomized Phase II 65 Atypical Antipsychotics 65 Robotic Assisted 65 Serious Infections 65 Prostate Cancer Survival 65 Renal Insufficiency 65 Better Outcomes 65 Combination REOLYSIN R 65 Etanercept 65 Golimumab 65 Radiation Induced 65 Initiates Phase III 65 Abstracts Accepted 65 Prostate Cancer Outcomes 65 Wound Closure 65 Clinical Documentation 65 Hemoglobin Levels 65 Newly Diagnosed 65 Stem Cell Transplants 65 Occlusive Disease 65 Severe Acne 65 Endometrial Cancer 65 Viral Load 65 Clinically Significant 65 Cause Mortality 65 Randomised Trial 65 Anticancer Activity 65 Treatment Shows Promise 65 Pharmacokinetic Study 65 Visceral Fat 65 Metastatic Melanoma 65 Preclinical Study 65 Advanced Renal Cell 65 ACUITY trial 65 Prostate Cancer Vaccine 65 Acute Coronary Syndrome 65 Demonstrates Potent 65 Brentuximab Vedotin SGN 65 Anticoagulant 65 Low Dose 65 Completes Patient Enrollment 65 Data Suggest 65 Targeted Therapy 65 Oral Mucositis 65 Who Underwent 65 Warfarin Coumadin 65 Technological Advances 65 Unresectable 65 Angiographic 65 Stent Placement 65 Phase III Pivotal 65 Myoblast 65 Image Guided 65 Bone Marrow Cells 65 Soft Tissue Sarcoma 65 Oral Calcitonin 65 Blood Clots 65 EVEREST II 65 Gestational Diabetes 65 Colorectal Cancers 65 Demonstrated Significant 65 Diabetic Nephropathy 65 Non Invasive 65 Sleep Disordered Breathing 65 Treatment Approaches 65 Unmet Medical 65 Confirmatory Phase 65 Infected Patients 65 Valve Replacement 65 Benign Prostatic Hyperplasia 65 Liver Metastases 65 Randomized Controlled Trial 65 Complicated Skin 65 Sleep Disturbance 65 Multicenter Phase 65 Thyroid Hormone 65 Immune Cell 65 Hormone Therapy 65 Heart Failure Therapies 65 Liver Tumors 65 Novel Mechanism 65 Left Ventricular Dysfunction 65 Hypotension 65 Adult Stem Cell Therapy 65 Prolongs Life 65 Randomized Phase III 65 Oral Anticoagulants 65 Seasonal Influenza Vaccine 65 Hyperlipidemia 65 Randomized Double Blind Placebo 65 Phase 2a Trial 65 Confirms Efficacy 65 Successfully Treated 65 Sirolimus Eluting Stent 65 Phase Ib Clinical Trial 65 Heartburn Drugs 65 Single Dose 65 Antifungals 65 Anti Tumor Activity 64 Edge STudy 64 Systemic Sclerosis 64 Chronic Liver Disease 64 Prevent Stroke 64 CHARM Added 64 Embolic Protection Device 64 Inflammatory Disease 64 Endothelial Function 64 Liver Injury 64 Carotid Artery 64 Gene Mutation 64 Periodontal Disease 64 Glucose Monitoring 64 Aortic Dissection 64 Male Fertility 64 Diabetic Retinopathy 64 Diabetic Macular Edema 64 Expanded Indication 64 Progenitor Cells 64 Genes Linked 64 Initiates Clinical Trial 64 Muscle Function 64 Chronic Hepatitis B 64 LDL Cholesterol 64 Gastrointestinal Disorders 64 Effective Than 64 RE LY 64 Treatment Resistant 64 Cognitive Problems 64 Prostate Screening 64 Prostate Cancer Screening 64 Cholesterol Drug 64 Echocardiographic 64 Genetic Variants 64 RNAi Therapeutics 64 Breast Carcinoma 64 Follicular Lymphoma 64 Malignancies 64 Statistical Significance 64 Cardiac Function 64 Regenerative Cells 64 Randomised Controlled Trial 64 Advanced Ovarian Cancer 64 CHMP Opinion 64 Breast Tissue 64 Prostate AdenoCarcinoma Treatment 64 J Am Coll 64 Differential Diagnosis 64 Epilepsy Drugs 64 Hematological Cancers 64 Heart Transplants 64 Antiviral Activity 64 Nonalcoholic Fatty Liver Disease 64 Blood Pressure Lowering 64 CABG Surgery 64 Double Blind Randomized 64 Schizophrenia Drug 64 Psoriasis Patients 64 Iron Deficiency 64 Darbepoetin Alfa 64 Improve Patient 64 Urinary Catheter 64 Unstable angina 64 Suicidality 64 angiographic outcomes 64 Radiation Exposure 64 Osteoporotic 64 Aliskiren 64 Significantly Reduces 64 Bladder Cancer 64 Chemoradiation 64 Tyrosine Kinase Inhibitor 64 ACTEMRA TM 64 Arthritis Drugs 64 Phase IIa Clinical Trial 64 Angioedema 64 Is Well Tolerated 64 Heart Failure Therapy 64 Mitral Regurgitation 64 Low Incidence 64 Inflammatory Diseases 64 Efficacy Endpoints 64 Spinal Manipulation 64 Anti Tumor 64 Chronic Hepatitis C 64 PRoFESS 64 Endarterectomy 64 Blood Pressure Drugs 64 Patient Registry 64 Genetic Variant 64 CYPHER R Sirolimus Eluting 64 Squamous Cell Carcinoma 64 Antiepileptic Drug 64 Pulse Oximetry 64 ORLive Presents 64 Tigecycline 64 Levels Linked 64 Anthracycline 64 Sipuleucel T 64 RNAi Therapeutic 64 Preterm Birth 64 Hemolysis 64 Protein Interaction 64 Thrombus 64 Blood Pressure Monitoring 64 Hospitalization Rates 64 Xelox 64 Observational Study 64 Embolization 64 Refractory Hodgkin Lymphoma 64 Cholesterol Drugs 64 Improving Patient 64 Study Shows Significant 64 Cancer Stem Cells 64 Secondary Endpoints 64 Regimens 64 Achieves Primary Endpoint 64 Diabetic Neuropathic Pain 64 Lymph Nodes 64 Heart Failure Treatment 64 Successful Implementation 64 Hematologic 64 Experimental Vaccine 64 Lymphoma Patients 64 Antidepressants Linked 64 Chronic HCV 64 Lipid Lowering 64 Limb Ischemia 64 Chronic Constipation 64 Vitamin D Deficiency 64 Vertebral Fractures 64 Patient Satisfaction 64 Coronary Arteries 64 Shingles Vaccine 64 Gene Variant 64 Clinical Practice Guidelines 64 Glatiramer Acetate 64 Postherpetic Neuralgia 64 Atypical Hemolytic Uremic Syndrome 64 Fecal Incontinence 64 Test Detects 64 Artificial Pancreas 64 Cost Effectiveness 64 Teva Provides Update 64 Rheumatoid Arthritis Drug 64 Receives Orphan Drug Designation 64 Vertebroplasty 64 Treat Anemia 64 Pregnancy Linked 64 Diagnostic Tools 64 Shows Promise Against 64 Drug Approvals 64 Stable Angina 64 Immune Mediated 64 Antibiotic Use 64 EURIDIS 64 Telik Announces 64 Adenoma 64 Breast Cancers 64 Acute Renal Failure 64 Genes Involved 64 Dupuytren Contracture 64 Vaccine Protects Against 64 Mitral Valve Repair 64 Placebo Controlled Study 64 Smallpox Vaccination 64 Hedgehog Pathway 64 Iron Overload 64 entitled Formulary Advantages 64 Gastrointestinal Stromal Tumors 64 External Defibrillators 64 RE LY ® 64 Microplasmin 64 Aortic Aneurysms 64 Dose Ranging Study 64 Novel Inhibitor 64 Anticancer Drugs 64 Corneal Transplant 64 Predict Breast Cancer 64 Randomized Phase 64 Statin Use 64 AA Amyloidosis 64 Nilotinib 64 Immunotherapeutic 64 Obesity Linked 64 Oncology Compounds 64 Initiate Clinical Trial 64 Coronary Artery Disease 64 Hepatitis C Virus 64 Nosocomial Pneumonia 64 Rectal Cancer 64 Smooth Muscle 64 Arterial Disease 64 Natalizumab 64 Pirfenidone 64 Node Positive 64 Adjunctive Therapy 64 Induction Therapy 64 Immunologic 64 Waist Size 64 Brain Atrophy 64 ARIXTRA R 64 Non Alcoholic Fatty 64 ENDEAVOR IV 64 Disease Modifying 63 Slows Progression 63 Asthma Symptoms 63 Cholesterol Lowering Drugs 63 TNF Alpha 63 Events MACE 63 Enlarged Prostate 63 Coronary Intervention 63 Heterozygous Familial Hypercholesterolemia 63 Trial Evaluating 63 Lipid Lowering Treatment 63 Gene Mutations 63 Randomized Comparison 63 Renal Cell Carcinoma RCC 63 Prostate Tumors 63 Zoledronic Acid 63 Lipid Levels 63 Allergic Asthma 63 Neoplasms 63 Coronary Artery Bypass Grafting 63 Antibiotic Treatment 63 Early Diagnosis 63 Congestive Heart Failure 63 Diagnostic Criteria 63 Gender Differences 63 Diagnostic Tests 63 Adjunctive 63 C1 Inhibitor 63 Intravascular 63 Study Shows Benefits 63 Synthetic Peptide 63 Leukemias 63 Certain Cancers 63 Arrhythmias 63 Hematological 63 Clot Busting 63 Decitabine 63 Antidepressant Use 63 Bevacizumab 63 CLARITY TIMI 63 Psychiatric Disorders 63 Therapeutic Potential 63 Cardiac Biomarkers 63 Related Mortality 63 Intra Arterial 63 Mouse Model 63 Effectively Treats 63 Coronary Stent 63 AVI BioPharma Announces 63 Multicenter Study 63 Granted Orphan Drug 63 Clot Risk 63 Insulin Resistance 63 Postmarketing 63 Bipolar Disorders 63 Ventilator Associated 63 Telithromycin 63 Romiplostim 63 Sangamo BioSciences Announces 63 Psoriasis Drug 63 Naive Patients 63 Relapsed Refractory 63 Paclitaxel Carboplatin 63 Capsule Endoscopy 63 Dementia Risk 63 Acute Stroke 63 Diagnosis Treatment 63 Potentially Fatal 63 ER Visits 63 Metastases 63 Bronchiectasis 63 Renal Tumors 63 Efficacious 63 Anticoagulation 63 Strongly Linked 63 Stenosis 63 Bone Fractures 63 Vertebral Compression Fractures 63 Hsp# Inhibitor 63 Improves Quality 63 Inflammatory Bowel Diseases 63 Initiate Phase II 63 Pregnancy Outcomes 63 Intracranial 63 Improve Patient Safety 63 Antipsychotic Drugs 63 Tyrosine Kinase Inhibitors 63 Capsules CII 63 Chronic Cough 63 Diffuse Large B 63 LUMINATE 63 Anticancer Drug 63 Preterm Infants 63 Major Adverse Cardiac 63 Ventricular Tachycardia 63 REMINDER ORLive Presents 63 Erectile Dysfunction Drug 63 Aortic Valve 63 Colorectal Cancer Screening 63 Multicenter 63 Reduce Cardiovascular 63 Female Stress Urinary 63 Prolonged Survival 63 Transdermal Patch 63 Myocardial Perfusion 63 Peripheral Vascular Disease 63 Surgical Mesh 63 Therapeutic Effects 63 NICE SUGAR 63 Genes Associated 63 Cell Lymphoma 63 CLINICAL PHARMACOLOGY 63 Egg Freezing 63 Imaging Technique 63 Suicidal Ideation 63 Gum Disease 63 Val HeFT 63 Novel Compound 63 Spinal Fusion 63 Cell Transplants 63 Neurodegenerative 63 Testosterone Patch 63 Hepatitis C Patients 63 Contrast Enhanced 63 Liver Transplant Patients 63 Lower Extremity 63 Versus Placebo 63 Prospective Randomized Trial 63 Embolic 63 Node Negative 63 Intervention Effectiveness 63 Dose Ranging 63 Protein Linked 63 NAVISTAR R 63 Catheterization 63 Epoetin Alfa 63 Initiate Phase III 63 MR Angiography 63 Mesothelioma Treatment 63 Fabry Disease 63 Metabolic Endocrinology 63 Reduced Incidence 63 Chemotherapy Regimen 63 Genetic Defect 63 Biopharmaceutical Industry 63 Chronic Inflammation 63 Prostate Cancer Detection 63 Implantable Device 63 Cognitive Decline 63 Osteoporosis Treatment 63 Patient Recruitment 63 Elevated Levels 63 Gets FDA Clearance 63 Adenomas 63 Circulatory Support 63 Leukemia Cells 63 Afib 63 NATRECOR R 63 Lymph Node 63 Urinary Tract Infections 63 Community Acquired Pneumonia 63 Systemic Lupus Erythematosus

Back to home page